SHIELD TX (UK) LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +87%

  £1,215,442 → £2,273,114

• Cash

  -70.1%

  £546,635 → £163,242

• Net assets

  -26.6%

  -£101,638,093 → -£128,723,010

• Employees

  -8.3%

  12 → 11

• Operating profit

  +22.2%

  -£24,796,683 → -£19,303,432

• Profit before tax

  +7.4%

  -£29,375,303 → -£27,204,074

• Wages

  -14.7%

  £1,209,586 → £1,031,265

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. SHIELD TX (UK) LIMITED 2016-03-17 → present
2. IRON THERAPEUTICS (UK) LIMITED 2010-10-07 → 2016-03-17
3. SHIELD THERAPEUTICS (UK) LIMITED 2010-04-15 → 2010-10-07
4. SHIELD THERAPEUTICS LTD 2008-09-18 → 2010-04-15

Accounting basis

FRS 101 Reduced Disclosure Framework

Reporting scope

Standalone (parent only)

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Accordingly, after making appropriate enquiries, the Directors have at the time of approving these financial statements, a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and, consequently, consider that it is appropriate to adopt the going concern basis in preparing these financial statements”

Significant events

• “On 22 April 2025 the Company entered into an exclusive license agreement with VITAL-NET, Inc in Japan.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.